COMMUNIQUÉS West-GlobeNewswire

Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity
07/01/2025
Press Release – No. 2 / 2025 Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity Copenhagen, Denmark, January 7, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), [...]
Alkeus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07/01/2025
CAMBRIDGE, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that Michel [...]
AI in Healthcare: Light-it and Puppeteer Set a New Standard for Patient Care and Efficiency
07/01/2025
Light-it, a leading digital health company, introduces Puppeteer, an AI-powered platform poised to redefine the patient-provider relationship. See how it's transforming how providers and patients connect, communicate, [...]
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering
07/01/2025
IRVINE, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar [...]
Immix Biopharma Accelerates Enrollment in U.S. AL Amyloidosis Trial of NXC-201 CAR-T
07/01/2025
Successfully dosed 6 patients in safety run-in segment, now accelerating enrollment Positive data from first four patients announced December 2024 NXC-201 is the only one-time CAR-T therapy in development for AL [...]
Clearmind Medicine Announces Shareholders Meeting Results
07/01/2025
Vancouver, Canada, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel [...]
FOXO TECHNOLOGIES INC.’S BOARD OF DIRECTORS ANNOUNCES SPECIAL MEETING OF SHAREHOLDERS
07/01/2025
MINNEAPOLIS, MN, Jan. 07, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold a special meeting of its shareholders at 10.30am EST on Friday, January 17, 2025. The [...]
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
07/01/2025
Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth Initiatives LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: [...]
Anaptys to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07/01/2025
SAN DIEGO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president [...]
Renovaro Issues Shareholder Letter and Provides Corporate Update
07/01/2025
Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) , a pioneer in cancer diagnostics and therapeutics powered by artificial [...]
Healthcare Integrated Technologies welcomes Justin Freishtat as its Chief Capital Officer
07/01/2025
Knoxville, TN, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces the appointment of Justin Freishtat [...]
QualityStar Expands Global Reach with Premium, Physician-Founded Supplements Tailored for Every Lifestyle
07/01/2025
QualityStar, a physician-founded supplement company, is expanding globally with multi-benefit products designed to simplify wellness. By combining scientifically backed ingredients into single, comprehensive formulas, [...]
Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
AUSTIN, TX and DURHAM, NC, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) [...]
Sotera Health Company Appoints Vincent K. Petrella as Lead Independent Director
06/01/2025
CLEVELAND, Ohio, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the [...]
Teladoc Health to Participate in Upcoming Investor Conference
06/01/2025
PURCHASE, NY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer [...]
Umoja Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
SEATTLE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today announced that the [...]
Travere Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the 43 rd Annual J.P. Morgan [...]
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
06/01/2025
WAYNE, Pa., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS) (the “Company” or “Aclaris”), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno- [...]
MannKind Expands Executive Leadership Team
06/01/2025
Dominic Marasco, RPh, joins the company as President, Endocrine Business Unit, effective January 6, 2025 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD [...]

Pages